Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorUniversity Hospital, Basel, Switzerland

About this trial

This project is to:

1. Quantify differences in axonal integrity and organization in aMS versus naPMS patients. 2. Quantify changes in axonal integrity and organization in aMS versus naPMS patients over a two-year period. 3. Validate the combination of imaging parameters that best differentiate aMS versus naPMS patients using histopathology.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

active RRMS (n=100): Relapsing-remitting course and > 1 clinical relapse and/or signs of MRI activity (> 1 Gd enhancing lesion) during the last year before study enrollment.

non-active PMS (n=100): Progressive course (PPMS or SPMS) and no clinical relapses and/or signs of MRI activity during the last year before study enrollment.

Age 18-80 years old

No other neurological or psychiatric disorder

Disqualifiers

Pregnancy

Contraindication to MRI (eg, claustrophobia, metallic implants, pacemaker etc).

Inability to give consent

Trial population

The recruitment of MS patients will take place at the MS Clinic of the Department of Neurology (Neurologische Klinik und Poliklinik), University Hospital Basel (Universitätsspital Basel). Healthy subjects will be recruited by public announcements (i.e. advertisement/flyer) on the University Hospital's and the University's notice board.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • MRI

    Diagnostic test

    Each enrolled subject will undergo a MRI at baseline and a second MRI at 2 years (+/- 3 months) follow-up.

  • Neurocognitive examination for healthy subjects

    Other intervention

    Neurocognitive examination for healthy subjects will be performed at both baseline and follow-up

  • blood sampling

    Other intervention

    Each enrolled subject will undergo a blood sampling (10 ml) at baseline

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: MS patient group2 interventions
Group B: control group (HC)3 interventions

Trial outcomes

Primary outcomes

1

MRI- change in axonal integrity and organization over 2 years in aMS, naPMS and HC, by using machine learning techniques

After magnetic resonance (MR) data preprocessing (image denoising, standardization, bias field correction) classical machine learning techniques will be used to classify a number of MRI metrics which will be averaged over a number of regions of interest (ROIs) including (i) normal-appearing white and brain matter in brain lobes and cervical spinal cord, (ii) basal ganglia, (iii) thalamus, (vi) cerebellum, MS lesions. Complex input data (voxels/patches) will be generated to learn from, then a deep learning model for supervised classification will be defined to identify the combination of aMRI parameters that characterize aMS, naPMS and HC.

Time frame
at baseline and 2 years (+/- 3 months) after baseline

Secondary outcomes

1

Change in MUSIC Test

Neurocognitive examination. MUSIC is a rapid (about 10-12 min) multiple domain cognitive screening test reflecting the most frequently impaired cognitive domains in MS. At 20-30 points the performance is in the normal range, at 16-19 points there is at most slight cognitive dysfunction, at 11-15 points there is moderate cognitive dysfunction and at \<= 10 points there is a clear cognitive dysfunction.

Time frame
at baseline and 2 years (+/- 3 months) after baseline
2

Change in auditory verbal learning and memory test/ Verbaler Lern- und Merkfähigkeitstest (VLMT)

Questionnaire to investigate memory performance, learning and recall information. Five presentations of a 15-word list are given, each followed by attempted recall. This is followed by a second 15-word interference list (list B), followed by recall of list A. Delayed recall and recognition are also tested.

Time frame
at baseline and 2 years (+/- 3 months) after baseline
3

Change in Symbol Digital Modalities Test (SDMT)

The SDMT detects cognitive impairment by measuring the time to pair abstracts. Using a reference key, the test taker has 90 seconds to pair specific numbers with given geometric figures.

Time frame
at baseline and 2 years (+/- 3 months) after baseline
4

Change in Brief Visuospatial Memory Test (BVMT)

The BVMT measures visuospatial memory In three Learning Trials, the respondent views the stimulus page for 10 seconds and is asked to draw as many of the figures as possible in their correct location on a page in the response booklet. A Delayed Recall Trial is administered after a 25-minute delay. Last, a Recognition Trial, in which the respondent is asked to identify which of 12 figures were included among the original geometric figures, is administered. Slower processing speed is associated with poorer learning and memory performance.

Time frame
at baseline and 2 years (+/- 3 months) after baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Basel, Switzerland

Lead sponsor

Swiss National Science Foundation

Collaborator